Triumph Group Q3 Earnings Beat Estimates, Sales Increase Y/Y — Positive
TGI Zacks Investment Research — February 10, 2025TGI's total sales in the third quarter of fiscal 2025 surpass the Zacks Consensus Estimate by 10.1%. The top line also increases 10.7% from the year-ago level.
Fortive Q4 Earnings Beat Estimates, Revenues Increase Y/Y — Positive
FTV Zacks Investment Research — February 10, 2025FTV reports strong fourth-quarter fiscal 2024 results, with both revenues and earnings increasing year over year.
Pilgrim's Pride Gears Up for Q4 Earnings: Here's What You Should Know — Positive
PPC Zacks Investment Research — February 10, 2025PPC's Q4 results are likely to gain from strategic investments, strong foodservice growth and an innovative product pipeline, reinforcing its competitive edge.
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of AstraZeneca PLC (AZN) Shareholders — Neutral
AZN Accesswire — February 10, 2025NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your AstraZeneca PLC (NASDAQ:AZN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/astrazeneca-plc-lawsuit-submission-form?prid=128429&wire=1 or contact Joseph E. Levi, Esq.
Electronic Arts Inc. Investigation Ongoing: Contact Levi & Korsinsky to Discuss Your Rights - EA — Neutral
EA Accesswire — February 10, 2025NEW YORK, NY / ACCESS Newswire / February 10, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Electronic Arts Inc. ("Electronic Arts Inc.") (NASDAQ:EA) concerning possible violations of federal securities laws. On January 22, 2025, EA issued a press release pre-announcing their preliminary Q3 FY25 results and announcing a guide-down from the company's prior expectations.
Investors who Lost Money on Innovative Industrial Properties, Inc.(IIPR) Should Contact Levi & Korsinsky About Pending Class Action - IIPR — Neutral
IIPR Accesswire — February 10, 2025NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your Innovative Industrial Properties, Inc. (NYSE:IIPR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/innovative-industrial-properties-inc-lawsuit-submission-form?prid=128442&wire=1 or contact Joseph E. Levi, Esq.
Shareholders of Applied Therapeutics, Inc. Should Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights - APLT — Neutral
APLT Accesswire — February 10, 2025NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=128433&wire=1 or contact Joseph E. Levi, Esq.
Class Action Filed Against ESSA Pharma Inc. (EPIX) Seeking Recovery for Investors - Contact Levi & Korsinsky — Neutral
EPIX Accesswire — February 10, 2025NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your ESSA Pharma Inc. (NASDAQ:EPIX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/essa-pharma-inc-lawsuit-submission-form?prid=128436&wire=1 or contact Joseph E. Levi, Esq.
Big pharma has come under a lot of scrutiny from regulators and consumers as sentiment sours on the industry. As such, the market can be unforgiving when companies even slightly miss expectations or forecasts.
Pacira BioSciences, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before March 14, 2025 to Discuss Your Rights - PCRX — Neutral
PCRX Accesswire — February 10, 2025NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your Pacira BioSciences, Inc. (NASDAQ:PCRX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/pacira-biosciences-inc-lawsuit-submission-form?prid=128435&wire=1 or contact Joseph E. Levi, Esq.
February 14, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against MGPI — Neutral
MGPI Accesswire — February 10, 2025NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your MGP Ingredients, Inc. (NASDAQ:MGPI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/mgp-ingredients-inc-lawsuit-submission-form?prid=128437&wire=1 or contact Joseph E. Levi, Esq.
Class Action Filed Against TELUS International (Cda) Inc. (TIXT) - March 31, 2025 Deadline to Join - Contact Levi & Korsinsky — Neutral
TIXT Accesswire — February 10, 2025NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your TELUS International (Cda) Inc. (NYSE:TIXT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/telus-international-lawsuit-submission-form?prid=128438&wire=1 or contact Joseph E. Levi, Esq.
Levi & Korsinsky Reminds FTAI Aviation Ltd. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 18, 2025 - FTAI — Neutral
FTAI Accesswire — February 10, 2025NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your FTAI Aviation Ltd. (NASDAQ:FTAI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/ftai-aviation-ltd-lawsuit-submission-form?prid=128426&wire=1 or contact Joseph E.
Regeneron Pharmaceuticals, Inc. Class Action: Levi & Korsinsky Reminds Regeneron Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 10, 2025 - REGN — Neutral
REGN Accesswire — February 10, 2025NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/regeneron-pharmaceuticals-inc-lawsuit-submission-form?prid=128427&wire=1 or contact Joseph E. Levi, Esq.
Integral Ad Science Holding Corp. Class Action: Levi & Korsinsky Reminds Integral Ad Science Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 31, 2025 - IAS — Neutral
IAS Accesswire — February 10, 2025NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your Integral Ad Science Holding Corp. (NASDAQ:IAS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/integral-ad-science-lawsuit-submission-form?prid=128441&wire=1 or contact Joseph E. Levi, Esq.
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of March 31, 2025 in Walgreens Lawsuit - WBA — Neutral
WBA Accesswire — February 10, 2025NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your Walgreens Boots Alliance, Inc. (NASDAQ:WBA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/walgreens-boots-alliance-inc-lawsuit-submission-form-2?prid=128430&wire=1 or contact Joseph E. Levi, Esq.
Levi & Korsinsky Investigates Possible Securities Fraud Violations by CARGO Therapeutics, Inc. (CRGX) — Neutral
CRGX Accesswire — February 10, 2025NEW YORK, NY / ACCESS Newswire / February 10, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of CARGO Therapeutics, Inc. ("CARGO Therapeutics, Inc.") (NASDAQ:CRGX) concerning possible violations of federal securities laws. On January 29, 2025, CARGO announced in a press release that it "has elected to discontinue FIRCE-1, a Phase 2 clinical study of firi-cel for patients with large B-cell lymphoma (LBCL) whose disease relapsed or was refractory (R/R) to CD19 CAR T-cell therapy.
Cardlytics, Inc. Class Action: Levi & Korsinsky Reminds Cardlytics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025 - CDLX — Neutral
CDLX Accesswire — February 10, 2025NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your Cardlytics, Inc. (NASDAQ:CDLX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/cardlytics-lawsuit-submission-form?prid=128432&wire=1 or contact Joseph E. Levi, Esq.
Lost Money on GSK plc(GSK)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky — Neutral
GSK Accesswire — February 10, 2025NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/gsk-lawsuit-submission-form?prid=128434&wire=1 or contact Joseph E. Levi, Esq.
Micron Technology, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - MU — Neutral
MU Accesswire — February 10, 2025NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your Micron Technology, Inc. (NASDAQ:MU) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/micron-technology-inc-lawsuit-submission-form?prid=128421&wire=1 or contact Joseph E. Levi, Esq.
